News Shortcuts from other journals

Candidate malaria vaccine looks safe and potentially effective

BMJ 2007; 335 doi: (Published 25 October 2007) Cite this as: BMJ 2007;335:851

International efforts to control malaria include developing and testing new vaccines directed against the pre-erythrocytic stage of Plasmodium falciparum. RTS,S/AS02D, a candidate manufactured by GlaxoSmithKline, has reached the stage of preliminary testing in humans, and early results look promising

View Full Text

Sign in

Log in through your institution

Free trial

Register for a free trial to to receive unlimited access to all content on for 14 days.
Sign up for a free trial